Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 2.610
-0.030 (-1.14%)
Sep 18, 2026, 4:00 PM EST
Cardiol Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -34.08 | -33.82 | -36.68 | -28.13 | -30.93 | -31.64 |
Depreciation & Amortization | 0.09 | 0.1 | 0.37 | 0.25 | 0.22 | 0.22 |
Asset Writedown & Restructuring Costs | - | - | - | - | 1.36 | 0.08 |
Stock-Based Compensation | 11.23 | 10.7 | 14.28 | 4.17 | 5.54 | 12.61 |
Other Operating Activities | -0.94 | -0.11 | -2.1 | -0.93 | -9.15 | -4.89 |
Change in Accounts Receivable | -0.01 | 0.04 | 0.04 | 0.07 | -0.14 | -0.06 |
Change in Inventory | - | - | - | - | - | 0.02 |
Change in Accounts Payable | 1.21 | 0.26 | -1.06 | -1.29 | 4.47 | 2.39 |
Change in Other Net Operating Assets | -1.56 | -1.04 | 0.09 | 0.68 | 1.42 | -2.27 |
Operating Cash Flow | -24.05 | -23.85 | -25.06 | -25.18 | -27.22 | -23.54 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.06 | -0.02 | -0.02 | -0.06 | -0.07 | -0.01 |
Investing Cash Flow | -0.06 | -0.02 | -0.02 | -0.06 | -0.07 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 |
Lease Payments | -0.06 | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 |
Net Debt Issued (Repaid) | -0.06 | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 |
Issuance of Common Stock | 33.38 | 16.07 | 21.53 | - | - | 98.72 |
Other Financing Activities | -1.71 | -0.48 | -2.65 | - | - | -5.23 |
Financing Cash Flow | 31.61 | 15.54 | 18.84 | -0.06 | -0.05 | 93.44 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.38 | -0.82 | 1.89 | 0.76 | 2.92 | -0.01 |
Net Cash Flow | 7.89 | -9.16 | -4.35 | -24.54 | -24.43 | 69.87 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -24.1 | -23.88 | -25.08 | -25.24 | -27.3 | -23.55 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | - | - | -29904.22% |
Free Cash Flow Per Share | -0.24 | -0.28 | -0.35 | -0.39 | -0.44 | -0.55 |
Levered Free Cash Flow | -15.48 | -13.03 | -11.71 | -14.99 | -20.64 | -4.61 |
Unlevered Free Cash Flow | -15.48 | -13.03 | -11.71 | -14.99 | -20.64 | -4.61 |
Free Cash Flow After Leases | -24.16 | -23.93 | -25.12 | -25.3 | -27.35 | -23.6 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | -0.36 | -0.73 | -0.93 | -0.55 | 5.75 | 0.08 |